Sponsors
Read more
Founded and situated in Lund with operations in Sweden, Norway, Denmark and United Kingdom we are a highly skilled organization aiming at expanding our business internationally and to raise awareness of sleep disorders and its impact on quality of life.
Why Lund Spring Symposium.
AGB-Pharma is keen to build collaborations between academia and industry and is proud to support Lund Spring Symposium and contribute to this significant event.
Read more
The society’s main task is to support scientific research, i.a. a. by actively participating in the organization of scientific symposia. Contributing to this symposium, which is of high scientific relevance, is thus completely in line with the Society’s objectives.
Read more
This was decisive for the establishment of the Medicon Village research park and the takeover of AstraZeneca’s premises in Lund. Medicon Village today offers a unique environment for life science by integrating research, innovation and entrepreneurship. With the foundation as the owner of Medicon Village, surplus from the operation goes back to research and innovation. By supporting the Lund Spring Symposium, the foundation wishes to promote international knowledge exchange between prominent researchers and at the same time position Skåne as a leading life science region.
Read more
Through a comprehensive scientific programme, we aim to unravel basic disease mechanisms, improve diagnostic precision, and develop efficient methods of treatment and care for people affected by neurodegenerative diseases. Building on a tradition of excellence in dopamine research at Lund University, the MultiPark programme was initially focused on Parkinson’s disease. However, our network has gradually expanded to incorporate excellent research on Alzheimer´s, Huntington´s, and neurodegenerative conditions after brain trauma and stroke.
One of the goals of MultiPark is to address unmet medical needs and develop improved treatments for patients affected by neurodegenerative disorders. To this end, an excellent programme of translational pharmacology is crucial. Our network is therefore pleased to support the Lund Spring Symposium, which will help raise the profile of pharmacological research at Lund University while stimulating new collaborations between academia and industry.